Above Meets Beyond
For appointments, call 1.804.828.2467
Appointment Request Emergency Room Tour Our Facilities

Bimota Nambam, MD

Bimota Nambam, MD

Assistant professor

Endocrinology and Metabolism

Center for Endocrinology, Diabetes and Metabolism
Children's Pavilion

Appointments: (804) 828-CHOR (2467)

Board Certifications

Pediatric Endocrinology

Medical School

Lady Hardinge Medical College, Delhi University


Children's Hospital at University of Illinois, Chicago


University of Florida at Gainesville, Shands Children's Hospital

Areas of Interest

Bone metabolism and health
Thyroid disorders
Adrenal disorders
Disorders of sexual development
Hypoglycemic disorders
Medical student and resident teaching

Research Interests

Type 1 diabetes

Recent Publications

Karlin S, Nambam B, Lacassie Y. Bardet-Biedl syndrome due to a pathogenic mutation on CEP290 and an unreported TTC8 variant. OA Journal of Clinical Case Reports (2018) 1:1

Nambam B, Bratina N, and Schatz D. Immune Intervention for Type 1 Diabetes. Diabetes Technology & Therapeutics. February 2018, 20 (S1): S-86-S-93.

Nambam B, Schatz D. Growth hormone and insulin-like growth factor-I axis in type 1 diabetes. Growth Hormone & IGF Research (2017), j.ghir.2017.12.005

Nambam B, Menefee E, Gungor N, McVie R. Severe complications after initial management of hyperglycemic hyperosmolar syndrome and diabetic ketoacidosis with a standard diabetic ketoacidosis protocol. J Pediatr Endocrinol Metab. 2017 Oct 26; 30 (11):1141-1145. doi: 10.1515/jpem-2017-0183.

Nambam B, Bratina N, and Schatz D. Immune interventions in type 1 diabetes. Diabetes Technology & Therapeutics. February 2017, 19 (S1): S-74-S-81.

Nambam B, Haller MJ. Updates on Immune Therapies in Type 1 Diabetes. European Endocrinology, 2016; 12 (2): 89–95.

Gupta N, Nambam B, Weinstein DA, Shoemaker LR. Late Diagnosis of Fanconi-Bickel Syndrome: Challenges with the Diagnosis and Literature of Review. Journal of Inborn Errors of Metabolism and Screening. 2016; 4: 1–6 DOI: 10.1177/2326409816679430

Nambam B, Bratina N, Schatz D. Immune interventions in type 1 diabetes. Diabetes Technology & Therapeutics. February 2016, 18(S1): S-69-S-75.

Nambam B, Silverstein J, Cheng P, et al. for the Pediatric Diabetes Consortium. A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. Pediatr Diabetes. 2017 May; 18 (3):222-229. doi: 10.1111/pedi.12377. Epub 2016 Mar 11.

Nambam B, DuBose SN, Nathan BM, et al for the T1D Exchange Clinic Network. Therapeutic inertia: underdiagnosed and undertreated hypertension in children participating in the T1D Exchange Clinic Registry. Pediatr Diabetes. 2014 Oct 21. doi: 10.1111/pedi.12231.

Nambam B, Hirsch IB, Danne T, Schatz DA. Lowering targets for hemoglobin A1c in children with type 1 diabetes: raising the bar. Pediatr Diabetes. Article first published online: 13 Nov 2014. doi: 10.1111/pedi.12244

Nambam B, Winter WE, Schatz DA. lgG4 Antibodies in Autoimmune Polyglandular Disease and lgG4-related Endocrinopathies: Pathophysiology and Clinical Characteristics. Curr Opin Pediatr. 2014 Aug; 26 (4):493-499.


Dr. Nambam is a member of the American Academy of Pediatrics, Pediatric Endocrine Society, Endocrine Society and American Diabetes Association.

Find A Provider

Get Directions

For Appointments,
Call 1.804.828.2467.

Facebook Twitter YouTube